Investigation of serum level relationship of pro-inflammatory and anti-inflammatory cytokines with vitamin D among healthy Ghanaian population.
25(OHD) deficiency
Blood donors
Ghana
IFN-gamma
IL 10
TNF-alpha
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
received:
28
09
2023
accepted:
14
02
2024
medline:
5
3
2024
pubmed:
5
3
2024
entrez:
4
3
2024
Statut:
epublish
Résumé
The interplay between vitamin D status and inflammatory cytokines in a supposedly sufficient sunshine environment has not well been evaluated. The study sought to determine their association. This cross-sectional study involved 500 healthy adult blood donors from some selected hospitals in Ghana enrolled from June to November 2016. Venous blood samples were obtained from participants, 25(OH)D, TNF-alpha, IFN-gamma, and IL 10 were measured using enzyme linked immunosorbent assay (ELISA) technique. Serum levels of 25(OH)D < 20ng/ml were classified as being deficient or low. The average age of the participants was 27.97 years. No statistically significant association was established between 25(OH) D status, mean age (p = 0.1693), and gender (p = 0.5461) of study participants. Similarly, the median 25(OH) D (p = 0.8392), IL-10 (p = 0.5355), TNF-alpha (p = 0.9740), and IFN-gamma (p = 0.6908) were not significantly different across gender. There was a significantly increased levels of TNF-alpha (p < 0.0001) and IFN-gamma (p < 0.0001) among participants with 25(OH) D deficiency compared to those without deficiency. Concurrently, participants with 25(OH)D deficiency had a significantly reduced levels of IL-10 (p < 0.0001) compared to those without 25 (OH) D deficiency. The most accurate biochemical markers for identifying 25 (OH) D deficiency were IFN-gamma (AUC = 0.879; p < 0.0001) followed by TNF-gamma (AUC = 0.849; p < 0.0001) and IL-10 (AUC = 0.707; p < 0.0001). There was a significant association between vitamin D levels and pro-inflammatory cytokines (TNF-alpha, IFN-gamma) and anti-inflammatory cytokine (IL 10) among healthy Ghanaian populace.
Sections du résumé
BACKGROUND
BACKGROUND
The interplay between vitamin D status and inflammatory cytokines in a supposedly sufficient sunshine environment has not well been evaluated. The study sought to determine their association.
METHODS
METHODS
This cross-sectional study involved 500 healthy adult blood donors from some selected hospitals in Ghana enrolled from June to November 2016. Venous blood samples were obtained from participants, 25(OH)D, TNF-alpha, IFN-gamma, and IL 10 were measured using enzyme linked immunosorbent assay (ELISA) technique. Serum levels of 25(OH)D < 20ng/ml were classified as being deficient or low.
RESULTS
RESULTS
The average age of the participants was 27.97 years. No statistically significant association was established between 25(OH) D status, mean age (p = 0.1693), and gender (p = 0.5461) of study participants. Similarly, the median 25(OH) D (p = 0.8392), IL-10 (p = 0.5355), TNF-alpha (p = 0.9740), and IFN-gamma (p = 0.6908) were not significantly different across gender. There was a significantly increased levels of TNF-alpha (p < 0.0001) and IFN-gamma (p < 0.0001) among participants with 25(OH) D deficiency compared to those without deficiency. Concurrently, participants with 25(OH)D deficiency had a significantly reduced levels of IL-10 (p < 0.0001) compared to those without 25 (OH) D deficiency. The most accurate biochemical markers for identifying 25 (OH) D deficiency were IFN-gamma (AUC = 0.879; p < 0.0001) followed by TNF-gamma (AUC = 0.849; p < 0.0001) and IL-10 (AUC = 0.707; p < 0.0001).
CONCLUSION
CONCLUSIONS
There was a significant association between vitamin D levels and pro-inflammatory cytokines (TNF-alpha, IFN-gamma) and anti-inflammatory cytokine (IL 10) among healthy Ghanaian populace.
Identifiants
pubmed: 38439034
doi: 10.1186/s13104-024-06721-y
pii: 10.1186/s13104-024-06721-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
64Informations de copyright
© 2024. The Author(s).
Références
Acar S, Özkan B. Vitamin D metabolism. Vitam D. 2021;2021:1–23.
Ismailova A, White JH. Vitamin D, infections and immunity. Reviews Endocr Metabolic Disorders, 2022: p. 1–13.
Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 2021;11(11):1624.
doi: 10.3390/biom11111624
pubmed: 34827621
pmcid: 8615708
El-Fakhri N, et al. Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Hormone Res Paediatrics. 2014;81(6):363–78.
doi: 10.1159/000357731
Al-Musharaf S. Prevalence of vitamin D deficiency in pregnant women and its association with gestational diabetes mellitus. University of Warwick; 2017.
Owens DJ. The role of vitamin D in skeletal muscle function and regeneration. Liverpool John Moores University (United Kingdom); 2015.
Bienaimé F, et al. Vitamin D metabolism and activity in the parathyroid gland. Mol Cell Endocrinol. 2011;347(1–2):30–41.
doi: 10.1016/j.mce.2011.05.031
pubmed: 21664247
Medrano M, et al. Vitamin D: effect on haematopoiesis and immune system and clinical applications. Int J Mol Sci. 2018;19(9):2663.
doi: 10.3390/ijms19092663
pubmed: 30205552
pmcid: 6164750
Szymczak I, Pawliczak R. The active metabolite of vitamin D3 as a potential immunomodulator. Scand J Immunol. 2016;83(2):83–91.
doi: 10.1111/sji.12403
pubmed: 26678915
Negishi Y, et al. Innate immune cells in reproduction. J Obstet Gynecol Res. 2018;44(11):2025–36.
doi: 10.1111/jog.13759
He C-S, et al. Is there an optimal vitamin D status for immunity in athletes and military personnel? Exerc Immunol Rev. 2016;22:42–64.
pubmed: 26853300
Van Etten E, et al. Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev. 2008;66(suppl 2):S125–34.
doi: 10.1111/j.1753-4887.2008.00096.x
pubmed: 18844839
Lucas RM et al. Vitamin D and immunity 2014.
Wimalawansa SJ. Infections and autoimmunity—the Immune System and vitamin D: a systematic review. Nutrients. 2023;15(17):3842.
doi: 10.3390/nu15173842
pubmed: 37686873
pmcid: 10490553
Abdo J, Rai V, Agrawal DK. Interplay of immunity and vitamin D: interactions and implications with current IBD therapy. Curr Med Chem. 2017;24(9):852–67.
doi: 10.2174/0929867323666161026124951
pubmed: 27784213
Bishop L. Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR plus. 2021;5(1):e10405.
doi: 10.1002/jbm4.10405
Pilz S et al. Effects of Vitamin D on Blood Pressure and Cardiovascular Risk Factors Hypertension, 2015: p. HYPERTENSIONAHA. 115.05319.
Stubbs JR, et al. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD. J Am Soc Nephrol. 2010;21(2):353–61.
doi: 10.1681/ASN.2009040451
pubmed: 20007751
pmcid: 2834546
Ross AC, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metabolism. 2011;96(1):53–8.
doi: 10.1210/jc.2010-2704
Zhang Y, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5):2127–35.
doi: 10.4049/jimmunol.1102412
pubmed: 22301548
Almerighi C, et al. 1α, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine. 2009;45(3):190–7.
doi: 10.1016/j.cyto.2008.12.009
pubmed: 19186073
Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25 (OH) D concentrations in healthy women. J Inflamm. 2008;5(1):10.
doi: 10.1186/1476-9255-5-10
Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–6.
doi: 10.2310/JIM.0b013e31821b8755
pubmed: 21527855
pmcid: 3166406
Sun X, et al. Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients. 2014;6(1):221–30.
doi: 10.3390/nu6010221
pubmed: 24451309
pmcid: 3916857
Khoo AL, et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Experimental Immunol. 2011;164(1):72–9.
doi: 10.1111/j.1365-2249.2010.04315.x
Baeke F, et al. Human T lymphocytes are direct targets of 1, 25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol. 2010;121(1–2):221–7.
doi: 10.1016/j.jsbmb.2010.03.037
pubmed: 20302932
Reich KM, et al. Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterology: WJG. 2014;20(17):4934.
doi: 10.3748/wjg.v20.i17.4934
pubmed: 24803805
pmcid: 4009525
Matilainen JM, et al. Primary effect of 1α, 25 (OH) 2D3 on IL-10 expression in monocytes is short-term down-regulation. Biochim et Biophys Acta (BBA)-Molecular Cell Res. 2010;1803(11):1276–86.
doi: 10.1016/j.bbamcr.2010.07.009
Yusupov E et al. Vitamin D and serum cytokines in a randomized clinical trial International journal of endocrinology, 2010. 2010.
Calton EK, et al. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS ONE. 2015;10(11):e0141770.
doi: 10.1371/journal.pone.0141770
pubmed: 26528817
pmcid: 4631349
Adegoke SA, et al. Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease. Cytokine. 2017;96:87–93.
doi: 10.1016/j.cyto.2017.03.010
pubmed: 28390266